Hitherto, our description of the proximity between malignant cells and LAG-3, activated CD8, regulatory FOXP3, and macrophages with Col III suggest that members of the TGF-β pathway may provide anti-NSCLC-immunity as previously reported by Budhu and colleagues (53). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.